The assessment of oxygen metabolism in the human retina has been a major focus of research in the past of the Section of Ophthalmo-Pharmacology and was already founded by two previous FWF projects.
“The grant will enable our team of researchers and PhD students to continue our research to employ cutting-edge technology and innovative methodologies for assessing and monitoring oxygen levels in the retina.”, so Dr. Gerhard Garhöfer, section head of Ophthalmo-Pharmacology at the Department of Clinical Pharmacology. Moreover, this grant represents a pivotal step towards the translation of new imaging methods usually used in basic research into practical applications. “The basic idea and long term-goal is to develop new imaging modalities that allow for the non-invasive risk stratification of patients with ocular and systemic diseases that are associated with altered oxygen metabolism.” explains Dr. Garhöfer.
The project has planned duration of 3 years and will be led by Dr. Doreen Schmidl as PI and supervised by Dr. Gerhard Garhöfer.